PSG recently announced that it had reached an agreement with French footballer Michael Olise, but this partnership does not concern the Parisian club itself. In fact, the Bayern Munich player signed a collaboration with the Nike brand, which aroused great interest among major European clubs and equipment manufacturers.
Michael Olise, who has emerged as one of Europe's most promising attacking talents, has long been the center of attention for PSG. The Parisian club studied the possibility of acquiring him while playing at Crystal Palace in 2024, before his transfer to Bayern Munich. Although Parisian interest was renewed in 2026, the complexity of the situation – notably Olise's key role in the Bavarian project and its potential cost – led PSG not to pursue the approach during the summer transfer window, according to information from L'Équipe.
In an unexpected twist, Nike chose to partner with Olise to strengthen its star portfolio following the loss of Kylian Mbappé, who left the brand for On. The player already wears Nike cleats, notably the Hypervenom Phantom III, although he is not officially affiliated with the equipment manufacturer. Nike plans to relaunch this range in 2027, with Olise as a potential ambassador, to capitalize on his popularity and style of play.
The details of the agreement remain to be officially confirmed, but specialist media such as Footy Headlines have already relayed the information. If PSG had considered recruiting Olise, Nike would have gone a step ahead by hiring him as their global face, reminiscent of the brand's strategy with other big names like Neymar. This collaboration could also open up new opportunities for Olise, both sportingly and commercially, while strengthening Nike's presence in European football.
In the future, developments in this alliance will need to be monitored. PSG may need to rethink their recruitment strategies, while Nike could take advantage of Olise's growing popularity to launch their new Hypervenom range. Fans and football experts are eagerly awaiting the official confirmation and first results of this collaboration.